series-c-plus
Stage
1
Investors
About
Firalis is a biotechnology company focused on the discovery, development, and qualification of biomarkers for diagnostic and therapeutic purposes. The company offers biomarker-based diagnostic, prognostic, and theranostic tools, including research-use-only kits and in vitro diagnostic tools, along with biomarker-related contract research organization (CRO) services.
Explore Firalis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.